The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has submitted an offer and entered into negotiations to acquire certain assets from Mithra Pharmaceuticals SA.
In the statement, Richter confirms that it has participated in the monetisation process of Mithra, which was publicly initiated by Mithra on 5 March 2024. Within the framework of the monetisation process, Richter has submitted an offer, but no binding agreement has been entered into yet. The exclusive negotiations are still ongoing.
Richter - in line with the company’s current practice - will announce the details of the transaction if and when all major elements and material details have been negotiated and finalized and the related transaction documentation has been signed.
Top 5 Articles
Duna House Profit Climbs Nearly 70% in Q3 November 24, 2025 
What Awaits the Hungarian Economy in 2026 and 2027? April 24, 2026 
'Recharge' Campaign Launched to Boost Domestic Tourism January 21, 2026 
Hungary’s Growth Stalls as Inflation Returns to Target Range February 6, 2026 
Business, Consumer Confidence at Two-Year High in April April 23, 2026
